Jade Biosciences, Inc. (JBIO) › Shareholders' EquityJade Biosciences, Inc. (JBIO) — Shareholders' EquityAnnual figures by period end, from SEC filings.2019-12-31: -$3.64M2020-12-31: -$13.34M2021-12-31: $172.42M2022-12-31: $126.74M2023-12-31: $109.46M2024-06-17: $1.0K2024-12-31: -$46.80M2025-12-31: $332.52M$332.52M2019-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$332.52M—2026-03-06Balance as of period end2024-12-31-$46.80M—2026-03-06Balance as of period end2024-06-17$1.0K—2026-03-06Balance as of period end2023-12-31$109.46M-13.6%2025-03-27Balance as of period end2022-12-31$126.74M-26.5%2025-03-27Balance as of period end2021-12-31$172.42M—2024-03-25Balance as of period end2020-12-31-$13.34M—2023-03-29Balance as of period end2019-12-31-$3.64M—2022-03-30Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)